spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baarends, W. M.
Right arrow Articles by et, al.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baarends, W. M.
Right arrow Articles by et, al.

Development, Vol 120, Issue 1 189-197, Copyright © 1994 by Company of Biologists

JOURNAL ARTICLES

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct

WM Baarends, MJ van Helmond, M Post, PJ van der Schoot, JW Hoogerbrugge, JP de Winter, JT Uilenbroek, B Karels, LG Wilming, JH Meijers and al. et
Department of Endocrinology and Reproduction, Faculty of Medicine and Health Sciences, Sophia Children's Hospital, Erasmus University, Rotterdam, The Netherlands.

The activin and TGF-beta type II receptors are members of a separate subfamily of transmembrane receptors with intrinsic protein kinase activity, which also includes the recently cloned TGF-beta type I receptor. We have isolated and characterized a cDNA clone (C14) encoding a new member of this subfamily. The domain structure of the C14-encoded protein corresponds with the structure of the other known transmembrane serine/threonine kinase receptors. It also contains the two inserts in the kinase domain that are characteristic for this subfamily. Using in situ hybridization, C14 mRNA was detected in the mesenchymal cells located adjacent to the mullerian ducts of males and females at day 15 (E15) of embryonic development. Marked C14 mRNA expression was also detected in the female gonads. In female E16 embryos, the C14 mRNA expression pattern remained similar to that in E15 embryos. However, in male E16 embryos C14 mRNA was detected in a circular area that includes the degenerating mullerian duct. The expression of C14 mRNA was also studied using RNase protection assays. At E15 and E16, C14 mRNA is expressed in the female as well as in the male urogenital ridge. However, at E19, a high C14 mRNA level in the female urogenital ridge contrasts with a lack of C14 mRNA in the male urogenital ridge. This correlates with the almost complete degeneration of the mullerian ducts in male embryos at E19. C14 mRNA expression was also detected in embryonic testes at E15, E16 and E19 using RNase protection assays, but at much lower levels than those found in the developing ovaries.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 EndocrinologyHome page
E. Shiraishi, N. Yoshinaga, T. Miura, H. Yokoi, Y. Wakamatsu, S.-I. Abe, and T. Kitano
Mullerian Inhibiting Substance Is Required for Germ Cell Proliferation during Early Gonadal Differentiation in Medaka (Oryzias latipes)
Endocrinology, April 1, 2008; 149(4): 1813 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert
Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2
Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
X. Yin, S. Ouyang, W. Xu, X. Zhang, K. L. Fok, H. Y. Wong, J. Zhang, X. Qiu, S. Miao, H. C. Chan, et al.
YWK-II protein as a novel Go-coupled receptor for Mullerian inhibiting substance in cell survival
J. Cell Sci., May 1, 2007; 120(9): 1521 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Pieretti-Vanmarcke, P. K. Donahoe, L. A. Pearsall, D. M. Dinulescu, D. C. Connolly, E. F. Halpern, M. V. Seiden, and D. T. MacLaughlin
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer
PNAS, November 14, 2006; 103(46): 17426 - 17431.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism
Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S J. Lin, T. F Lerch, R. W Cook, T. S Jardetzky, and T. K Woodruff
The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding.
Reproduction, August 1, 2006; 132(2): 179 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams
Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer.
Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S. Mazerbourg and A. J.W. Hsueh
Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands
Hum. Reprod. Update, July 1, 2006; 12(4): 373 - 383.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
Y. Zhan, A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe
Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression
Development, June 15, 2006; 133(12): 2359 - 2369.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Pieretti-Vanmarcke, P. K. Donahoe, P. Szotek, T. Manganaro, M. K. Lorenzen, J. Lorenzen, D. C. Connolly, E. F. Halpern, and D. T. MacLaughlin
Recombinant Human Mullerian Inhibiting Substance Inhibits Long-term Growth of MIS Type II Receptor-Directed Transgenic Mouse Ovarian Cancers In vivo
Clin. Cancer Res., March 1, 2006; 12(5): 1593 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Mazerbourg, K. Sangkuhl, C.-W. Luo, S. Sudo, C. Klein, and A. J. W. Hsueh
Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses
J. Biol. Chem., September 16, 2005; 280(37): 32122 - 32132.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard
AMH and AMH receptor defects in persistent Mullerian duct syndrome
Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
Y. Yin and L. Ma
Development of the Mammalian Female Reproductive Tract
J. Biochem., June 1, 2005; 137(6): 677 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Gupta, J. L. Carey, H. Kawakubo, A. Muzikansky, J. E. Green, P. K. Donahoe, D. T. MacLaughlin, and S. Maheswaran
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
PNAS, March 1, 2005; 102(9): 3219 - 3224.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. J. Renaud, D. T. MacLaughlin, E. Oliva, B. R. Rueda, and P. K. Donahoe
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
PNAS, January 4, 2005; 102(1): 111 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
P. Jeyasuria, Y. Ikeda, S. P. Jamin, L. Zhao, D. G. de Rooij, A. P. N. Themmen, R. R. Behringer, and K. L. Parker
Cell-Specific Knockout of Steroidogenic Factor 1 Reveals Its Essential Roles in Gonadal Function
Mol. Endocrinol., July 1, 2004; 18(7): 1610 - 1619.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Belville, H. Van Vlijmen, C. Ehrenfels, B. Pepinsky, A. R. Rezaie, J.-Y. Picard, N. Josso, N. d. Clemente, and R. L. Cate
Mutations of the Anti-Mullerian Hormone Gene in Patients with Persistent Mullerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model
Mol. Endocrinol., March 1, 2004; 18(3): 708 - 721.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson
The Bone Morphogenetic Protein System In Mammalian Reproduction
Endocr. Rev., February 1, 2004; 25(1): 72 - 101.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
A. Kobayashi, W. Shawlot, A. Kania, and R. R. Behringer
Requirement of Lim1 for female reproductive tract development
Development, February 1, 2004; 131(3): 539 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. J. Pask, D. J. Whitworth, C.-A. Mao, K.-J. Wei, N. Sankovic, J. A. M. Graves, G. Shaw, M. B. Renfree, and R. R. Behringer
Marsupial Anti-Mullerian Hormone Gene Structure, Regulatory Elements, and Expression
Biol Reprod, January 1, 2004; 70(1): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, and T. C. Hamilton
Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer
Cancer Res., March 15, 2003; 63(6): 1389 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
L. M. Roberts, J. A. Visser, and H. A. Ingraham
Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development
Development, March 5, 2003; 129(6): 1487 - 1496.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation
Endocrinology, September 1, 2002; 143(9): 3351 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, H. A. Ingraham, M. W. Nachtigal, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Endocrinology, March 1, 2002; 143(3): 1076 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, T. R. Kumar, M. M. Matzuk, U. M. Rose, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, et al.
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Endocrinology, November 1, 2001; 142(11): 4891 - 4899.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey
Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
Endocrinology, September 1, 2001; 142(9): 4040 - 4046.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. A. Hughes
Minireview: Sex Differentiation
Endocrinology, August 1, 2001; 142(8): 3281 - 3287.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A. P. N. Themmen, and H. A. Ingraham
The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling
Mol. Endocrinol., June 1, 2001; 15(6): 936 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. R. Clarke, Y. Hoshiya, S. E. Yi, X. Liu, K. M. Lyons, and P. K. Donahoe
Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression
Mol. Endocrinol., June 1, 2001; 15(6): 946 - 959.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. T. MacLaughlin, J. Teixeira, and P. K. Donahoe
Perspective: Reproductive Tract Development--New Discoveries and Future Directions
Endocrinology, June 1, 2001; 142(6): 2167 - 2172.
[Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Nef and L. F. Parada
Hormones in male sexual development
Genes & Dev., December 15, 2000; 14(24): 3075 - 3086.
[Full Text]

Home page
 DevelopmentHome page
S Allard, P Adin, L Gouedard, N di Clemente, N Josso, M. Orgebin-Crist, J. Picard, and F Xavier
Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin
Development, January 8, 2000; 127(15): 3349 - 3360.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, P. Kramer, B. Karels, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen
Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary
Endocrinology, December 1, 1999; 140(12): 5789 - 5796.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Teixeira, D. J. Kehas, R. Antun, and P. K. Donahoe
Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells
PNAS, November 23, 1999; 96(24): 13831 - 13838.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al.
Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS
Clin. Cancer Res., November 1, 1999; 5(11): 3488 - 3499.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Teixeira, E. Fynn-Thompson, A. H. Payne, and P. K. Donahoe
Mullerian-Inhibiting Substance Regulates Androgen Synthesis at the Transcriptional Level
Endocrinology, October 1, 1999; 140(10): 4732 - 4738.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. M. Lee, C. C. Seah, P. T. Masiakos, C. M. Sottas, F. I. Preffer, P. K. Donahoe, D. T. MacLaughlin, and M. P. Hardy
Mullerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig Cells
Endocrinology, June 1, 1999; 140(6): 2819 - 2827.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
Y. Mishina, D. J. Whitworth, C. Racine, and R. R. Behringer
High Specificity of Mullerian-Inhibiting Substance Signaling in Vivo
Endocrinology, May 1, 1999; 140(5): 2084 - 2088.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. d. S. Barbara, B. Moniot, F. Poulat, B. Boizet, and P. Berta
Steroidogenic Factor-1 Regulates Transcription of the Human Anti-mullerian Hormone Receptor
J. Biol. Chem., November 6, 1998; 273(45): 29654 - 29660.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. K. Arambepola, D. Bunick, and P. S. Cooke
Thyroid Hormone and Follicle-Stimulating Hormone Regulate Mullerian-Inhibiting Substance Messenger Ribonucleic Acid Expression in Cultured Neonatal Rat Sertoli Cells
Endocrinology, November 1, 1998; 139(11): 4489 - 4495.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Visser, A. McLuskey, M. Verhoef-Post, P. Kramer, J. A. Grootegoed, and A. P. N. Themmen
Effect of Prenatal Exposure to Diethylstilbestrol on Mullerian Duct Development in Fetal Male Mice
Endocrinology, October 1, 1998; 139(10): 4244 - 4251.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. Rouiller-Fabre, S. Carmona, R. A. Merhi, R. Cate, R. Habert, and B. Vigier
Effect of Anti-Mullerian Hormone on Sertoli and Leydig Cell Functions in Fetal and Immature Rats
Endocrinology, March 1, 1998; 139(3): 1213 - 1220.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Racine, R. Rey, M. G. Forest, F. Louis, A. Ferre, I. Huhtaniemi, N. Josso, and N. di Clemente
Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation
PNAS, January 20, 1998; 95(2): 594 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
C. M. HAQQ and P. K. DONAHOE
Regulation of Sexual Dimorphism in Mammals
Physiol Rev, January 1, 1998; 78(1): 1 - 33.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. A. Catlin, V. C. Tonnu, R. G. Ebb, B. A. Pacheco, T. F. Manganaro, R. M. Ezzell, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Inhibits Branching Morphogenesis and Induces Apoptosis in Fetal Rat Lung
Endocrinology, February 1, 1997; 138(2): 790 - 796.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
G Giuili, W. Shen, and H. Ingraham
The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo
Development, January 5, 1997; 124(9): 1799 - 1807.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
E. Faure, L. Gouedard, S. Imbeaud, R. Cate, J.-Y. Picard, N. Josso, and N. di Clemente
Mutant Isoforms of the Anti-Mullerian Hormone Type II Receptor Are Not Expressed at the Cell Membrane
J. Biol. Chem., November 29, 1996; 271(48): 30571 - 30575.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Ryden, T. Imamura, H. Jornvall, N. Belluardo, I. Neveu, M. Trupp, T. Okadome, P. ten Dijke, and C. F. Ibanez
A Novel Type I Receptor Serine-Threonine Kinase Predominantly Expressed in the Adult Central Nervous System
J. Biol. Chem., November 29, 1996; 271(48): 30603 - 30609.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
Y Mishina, R Rey, M J Finegold, M M Matzuk, N Josso, R L Cate, and R R Behringer
Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.
Genes & Dev., October 15, 1996; 10(20): 2577 - 2587.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
D.èl. C. Eusèbe, N. di Clemente, R. Rey, C. Pieau, B. Vigier, N. Josso, and J.-Y. Picard
Cloning and Expression of the Chick Anti-Müllerian Hormone Gene
J. Biol. Chem., March 1, 1996; 271(9): 4798 - 4804.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
D. Whitworth, G Shaw, and M. Renfree
Gonadal sex reversal of the developing marsupial ovary in vivo and in vitro
Development, January 12, 1996; 122(12): 4057 - 4063.
[Abstract] [PDF]

Home page
 DevelopmentHome page
J Kent, S. Wheatley, J. Andrews, A. Sinclair, and P Koopman
A male-specific role for SOX9 in vertebrate sex determination
Development, January 9, 1996; 122(9): 2813 - 2822.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
T. Nohno, T. Ishikawa, T. Saito, K. Hosokawa, S. Noji, D. H. Wolsing, and J. S. Rosenbaum
Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors
J. Biol. Chem., September 22, 1995; 270(38): 22522 - 22526.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Kawabata, A. Chytil, and H. L. Moses
Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-beta Receptor
J. Biol. Chem., March 10, 1995; 270(10): 5625 - 5630.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Gouedard, Y.-G. Chen, L. Thevenet, C. Racine, S. Borie, I. Lamarre, N. Josso, J. Massague, and N. di Clemente
Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Mullerian Hormone and Its Type II Receptor
J. Biol. Chem., September 1, 2000; 275(36): 27973 - 27978.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. L. Segev, T. U. Ha, T. T. Tran, M. Kenneally, P. Harkin, M. Jung, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFkappa B-mediated Pathway
J. Biol. Chem., September 8, 2000; 275(37): 28371 - 28379.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. U. Ha, D. L. Segev, D. Barbie, P. T. Masiakos, T. T. Tran, D. Dombkowski, M. Glander, T. R. Clarke, H. K. Lorenzo, P. K. Donahoe, et al.
Mullerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
J. Biol. Chem., November 17, 2000; 275(47): 37101 - 37109.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. L. Segev, Y. Hoshiya, A. E. Stephen, M. Hoshiya, T. T. Tran, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates NFkappa B Signaling and Growth of Mammary Epithelial Cells in Vivo
J. Biol. Chem., July 13, 2001; 276(29): 26799 - 26806.
[Abstract] [Full Text] [PDF]

Home page